TBG Biotechnology
Media
Partnering
Language
English
繁體中文
简体中文
Reagents
COVID 19 Testing Kits
HLA SSP Typing Kits
HLA SBT Typing Kits
HPA Genotyping Kits
Reagents and Accessories
Reagent Analysis Software
HLA Real Time PCR Typing Kits
Nucleic Acid Extraction Kits
Urothelial Carcinoma Detection Tests
HLA NGS Typing Kits
Analysis Software
Equipments
Nucleic Acid Extraction Systems
Automated Pipetting System
Real Time PCR System
Service
HLA Genotyping
Manufacturing
Research & Development
Benefits of Molecular Diagnostics
Sequence Specific Primers
Sequencing Based Typing
Links to Resources
Developing Products
About TBG
Company Introduction
Our Vision
Our Board of Directors
Career Opportunities
Quality systems
Contact us
Investor Center
Financial Reports
Research
Presentations
Company Announcements
Corporate Governance
TBG Biotechnology
Home
/
Investor center
/
Company Announcements
Investor center
Company Announcements
Investor center
Financial Reports
Research
Presentations
Company Announcements
Corporate Governance
Company Announcements
Results of 2022 AGM
Results of 2022 EGM
NOTICE OF GENERAL ME0ETING (Meeting will be held on 28 October 2022)
Results of 2021 AGM and Shareholder Update